In silico virtual screening approaches for anti-viral drug discovery
- 4 August 2012
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Technologies
- Vol. 9 (3), e219-e225
- https://doi.org/10.1016/j.ddtec.2012.07.009
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Pharmacophore-based discovery of a novel cytosolic phospholipase A2α inhibitorBioorganic & Medicinal Chemistry Letters, 2012
- Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validationBioorganic & Medicinal Chemistry, 2011
- Pharmacophore Modeling and Virtual Screening for Novel Acidic Inhibitors of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1)Journal of Medicinal Chemistry, 2011
- Virtual Ligand Screening of the National Cancer Institute (NCI) Compound Library Leads to the Allosteric Inhibitory Scaffolds of the West Nile Virus NS3 ProteinaseASSAY and Drug Development Technologies, 2011
- Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsidBioorganic & Medicinal Chemistry, 2011
- Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screeningBioorganic & Medicinal Chemistry, 2010
- Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniquesBioorganic & Medicinal Chemistry Letters, 2010
- Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymeraseBioorganic & Medicinal Chemistry, 2010
- Emergence and pandemic potential of swine-origin H1N1 influenza virusNature, 2009
- Discovery of Wild-Type and Y181C Mutant Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors Using Virtual Screening with Multiple Protein StructuresJournal of Chemical Information and Modeling, 2009